What is the name of the laser treatment for glaucoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laser Treatments for Glaucoma

The primary laser treatments for glaucoma are laser trabeculoplasty (including argon laser trabeculoplasty [ALT] and selective laser trabeculoplasty [SLT]), laser peripheral iridotomy, and cyclophotocoagulation procedures. 1

Main Laser Procedures

Laser Trabeculoplasty

Laser trabeculoplasty works by increasing aqueous humor outflow through the trabecular meshwork and is positioned as a second-line treatment after medication therapy in the standard treatment algorithm. 1, 2

Types of Trabeculoplasty:

  • Argon Laser Trabeculoplasty (ALT): The original laser trabeculoplasty technique that demonstrated IOP reduction of 9 mmHg in the Glaucoma Laser Trial, superior to topical timolol (7 mmHg) over 2 years 1

  • Selective Laser Trabeculoplasty (SLT): A newer technique that is non-inferior to ALT in IOP reduction and achieving treatment success, with the advantage of being repeatable unlike ALT 1, 3

  • SLT has a better safety profile than ALT, causing less postoperative pain and inflammation, with mild anterior chamber inflammation being the most common side effect 1

  • 360-degree treatment with SLT is necessary to achieve comparable efficacy to prostaglandin analog therapy, as studies show 90 and 180-degree treatments have inferior IOP-lowering effects 1, 4

Cyclophotocoagulation Procedures

Cyclodestructive procedures reduce aqueous production by targeting the ciliary body and are traditionally reserved for refractory glaucomas. 1

Types of Cyclophotocoagulation:

  • Transscleral cyclophotocoagulation: Applied externally through the sclera, good for eyes with limited visual potential or poor candidates for incisional surgery 1

  • Endoscopic cyclophotocoagulation (ECP): Uses an 810-nm diode laser with direct visualization of ciliary processes, allowing better titration of treatment with IOP reduction of 34-57% 1

  • Micropulse transscleral cyclophotocoagulation: Delivers repetitive short bursts of diode laser energy with intervening rest periods, representing an alternative to traditional continuous-wave laser 1

Laser cyclophotocoagulation causes less postoperative pain and inflammation compared to cyclocryotherapy, which is now rarely used. 1

Other Laser Procedures

  • Laser peripheral iridotomy: Used primarily for angle-closure glaucoma, though long-term effectiveness for prevention of primary angle closure glaucoma remains undetermined 1

  • Laser iridoplasty: Adjunctive procedure for angle-closure situations 1

Treatment Algorithm Position

According to the American Academy of Ophthalmology, laser trabeculoplasty is indicated only after first-line and second-line medications have failed to control IOP. 2

  • Topical medications (prostaglandin analogs or beta-blockers) should be the initial treatment, with demonstrated IOP reduction of 25-49% in clinical trials 2

  • Laser trabeculoplasty is positioned as second-line treatment after medication failure or when patients cannot tolerate or adhere to medication regimens 2

Common Complications and Caveats

IOP spikes occur in 4.5-27% of eyes after SLT, similar to rates with ALT, with more heavily pigmented trabecular meshwork being more prone to pressure spikes 1

Cyclodestructive procedures carry risks including:

  • Postoperative inflammation and pain 1
  • Hypotony and cystoid macular edema 1
  • Vision loss and rarely sympathetic ophthalmia 1
  • Frequent need for repeat treatment weeks or months later 1

Perioperative management for laser trabeculoplasty requires:

  • IOP check within 30 minutes to 2 hours after surgery 1
  • Follow-up examination within 6 weeks or sooner if concern about IOP-related optic nerve damage 1
  • Medications like brimonidine or apraclonidine may be used perioperatively to prevent temporary IOP elevations 1

Critical Evidence Considerations

The Glaucoma Laser Trial demonstrated that initial laser trabeculoplasty was at least as effective as topical timolol in preserving visual field and optic disc status over 5.5-9 years of follow-up. 1

A multicenter randomized trial showed similar IOP reduction with SLT and medication groups after 1 year, though the study may have had insufficient statistical power to detect differences 1

Documentation of medication trials and failures is essential before proceeding to laser procedures to establish medical necessity and avoid unnecessary interventions 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trabeculoplasty Laser Surgery Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Status of Selective Laser Trabeculoplasty (SLT)].

Klinische Monatsblatter fur Augenheilkunde, 2017

Guideline

Minimally Invasive Glaucoma Surgery and Traditional Glaucoma Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.